Media coverage
13
Media coverage
Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock Media name/outlet Morningstar.com Country/Territory United States Date 18/04/23 URL https://www.morningstar.com/news/business-wire/20230418006201/exthera-medical-successfully-completes-phase-i-of-purify-rct-us-investigational-device-exemption-trial-evaluating-seraph-100-for-the-treatment-of-septic-shock Persons Ian Stewart Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock Media name/outlet Business Wire Country/Territory United States Date 18/04/23 URL www.businesswire.com/news/home/20230418006201/en/ExThera-Medical-Successfully-Completes-Phase-I-of-PURIFY-RCT-US-Investigational-Device-Exemption-Trial-Evaluating-Seraph-100-for-the-Treatment-of-Septic-Shock/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT Persons Ian Stewart Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock; A Prospective Interventional Multicenter Randomized Controlled Trial Media name/outlet Business Wire Country/Territory United States Date 18/04/23 URL metabase.moreover.com/noarticleurl?type=psh&lni=681W-CXK1-JBG1-83NC-00000-00 Persons Ian Stewart Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock Media name/outlet Street Insider Country/Territory United States Date 18/04/23 URL https://www.streetinsider.com/Press+Releases/ExThera+Medical+Successfully+Completes+Phase+I+of+PURIFY+RCT%3A+US+Investigational+Device+Exemption+Trial+Evaluating+Seraph+100+for+the+Treatment+of+Septic+Shock/21520308.html Persons Ian Stewart Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock Media name/outlet BioSpace Country/Territory United States Date 18/04/23 URL https://www.biospace.com/article/releases/exthera-medical-successfully-completes-phase-i-of-purify-rct-us-investigational-device-exemption-trial-evaluating-seraph-100-for-the-treatment-of-septic-shock/?s=105 Persons Ian Stewart Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock Media name/outlet Yahoo! Finance Country/Territory United States Date 18/04/23 URL https://finance.yahoo.com/news/exthera-medical-successfully-completes-phase-203500078.html Persons Ian Stewart Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock Media name/outlet TD Ameritrade Country/Territory United States Date 18/04/23 URL https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-108b9954-1 Persons Ian Stewart Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock Media name/outlet ADVFN US Country/Territory United States Date 18/04/23 URL https://www.advfn.com/p.php?pid=nmona&article=90796269 Persons Ian Stewart Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock Media name/outlet Le Lezard.com Country/Territory Canada Date 18/04/23 URL https://www.lelezard.com/en/news-20859541.html Persons Ian Stewart Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock Media name/outlet AIJourn.com Country/Territory United Kingdom Date 18/04/23 URL https://aijourn.com/press_release/exthera-medical-successfully-completes-phase-i-of-purify-rct-us-investigational-device-exemption-trial-evaluating-seraph-100-for-the-treatment-of-septic-shock/ Persons Ian Stewart Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock Media name/outlet Pharmaceutical Daily Country/Territory Bosnia and Herzegovina Date 18/04/23 URL https://pharmaceuticaldaily.com/exthera-medical-successfully-completes-phase-i-of-purify-rct-us-investigational-device-exemption-trial-evaluating-seraph-100-for-the-treatment-of-septic-shock/ Persons Ian Stewart Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock Media name/outlet CIT Country/Territory United States Date 18/04/23 URL www.businesswire.com/news/home/20230418006201/en/ExThera-Medical-Successfully-Completes-Phase-I-of-PURIFY-RCT-US-Investigational-Device-Exemption-Trial-Evaluating-Seraph-100-for-the-Treatment-of-Septic-Shock/?feedref=JjAwJuNHiystnCoBq_hl-fqXyBvmekC3Xq1G1wQ7hjMFbZM1ntlKeK-8bUzJqFSVSfe41V1BKA-b6v2ZVrSSNs-dUYKiDvY7XniNSqv88QcY1Ge_vf9QIMZ4alzIf_0HlyE0C4hZhHVlTvKnn0d0vQ== Persons Ian Stewart Title ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock Media name/outlet Bakersfield.com Country/Territory United States Date 18/04/23 URL https://www.bakersfield.com/ap/news/exthera-medical-successfully-completes-phase-i-of-purify-rct-us-investigational-device-exemption-trial-evaluating/article_b33d5ac9-8180-5023-88ba-e50e256e2a42.html Persons Ian Stewart